While vaccine sales dropped, GSK raised its revenue guidance for 2031 with speciality medicines expected to drive that growth ...

Adult and pediatric patients who received 2023-2024 influenza vaccines exhibited reduced risk for influenza-associated encounters across care settings.

Parental sociodemographic characteristics and COVID-19 vaccination status are associated with MMR vaccination rates in the United States.

February 5, 2025 - Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announced that the Medicines and Healthcare products Regulatory Agency (MHRA) ...

The packets provided information that is important for parents and identifies the requirements from the Pennsylvania ...